{
    "clinical_study": {
        "@rank": "127569", 
        "arm_group": [
            {
                "arm_group_label": "10 day Quadruple Therapy", 
                "arm_group_type": "Experimental", 
                "description": "Esomeprazole 20mg, Amoxicillin 1.0g, Clarithromycin 500mg and Bismuth Potassium Citrate 220mg,twice a day for 10 days"
            }, 
            {
                "arm_group_label": "10 day Triple therapy", 
                "arm_group_type": "Active Comparator", 
                "description": "Esomeprazole 20mg, Amoxicillin 1.0g,and Clarithromycin 500mg, twice a day, for ten days"
            }, 
            {
                "arm_group_label": "14 day quadruple therapy", 
                "arm_group_type": "Active Comparator", 
                "description": "Esomeprazole 20mg, Amoxicillin 1.0g, Clarithromycin 500mg and Bismuth Potassium Citrate 220mg,twice a day for 14 days"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to observe the efficacy of ten day triple therapy-based,\n      bismuth-containing quadruple therapy for H.pylori treatment."
        }, 
        "brief_title": "Efficiency Study of Clarithromycin and Bismuth-containing Quadruple Therapy to Treat H.Pylori", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Functional Dyspepsia", 
            "Peptic Ulcer", 
            "Helicobacter Pylori"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Dyspepsia", 
                "Peptic Ulcer", 
                "Ulcer"
            ]
        }, 
        "detailed_description": {
            "textblock": "The success rate of currently recommended triple therapy with a proton pump inhibitor (PPI)\n      plus amoxicillin and clarithromycin has fallen into the unacceptable range. The purpose of\n      this study is to observe the efficacy of ten day triple therapy-based, bismuth-containing\n      quadruple therapy for H.pylori treatment, while ten day triple therapy is used as control."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients who presented with upper gastrointestinal symptoms and endoscopically proven\n             H.pylori-positive functional dyspepsia and scarred peptic ulcers\n\n        Exclusion Criteria:\n\n          -  patients less than 18 years old, with history of H. pylori infection treatment, with\n             previous gastric surgery, pregnancy, lactation, major systemic diseases,\n             administration of antibiotics, bismuth, antisecretory drugs in the preceding 8 weeks,\n             or allergy to any one of the given medication in the regimens."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "180", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01667575", 
            "org_study_id": "rjkls2012004"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "10 day Quadruple Therapy", 
                    "10 day Triple therapy", 
                    "14 day quadruple therapy"
                ], 
                "description": "antisecretary drug of the quadruple therapy", 
                "intervention_name": "Esomeprazole", 
                "intervention_type": "Drug", 
                "other_name": "proton pump inhibitor"
            }, 
            {
                "arm_group_label": [
                    "10 day Quadruple Therapy", 
                    "10 day Triple therapy", 
                    "14 day quadruple therapy"
                ], 
                "description": "antibiotic  of the quadruple therapy", 
                "intervention_name": "Amoxicillin", 
                "intervention_type": "Drug", 
                "other_name": "antibiotic"
            }, 
            {
                "arm_group_label": [
                    "10 day Quadruple Therapy", 
                    "10 day Triple therapy", 
                    "14 day quadruple therapy"
                ], 
                "description": "antibiotic of the quadruple therapy", 
                "intervention_name": "Clarithromycin", 
                "intervention_type": "Drug", 
                "other_name": "antibiotic"
            }, 
            {
                "arm_group_label": [
                    "10 day Quadruple Therapy", 
                    "14 day quadruple therapy"
                ], 
                "description": "one of a component of a quadruple therapy", 
                "intervention_name": "Bismuth Potassium Citrate", 
                "intervention_type": "Drug", 
                "other_name": "Bismuth"
            }, 
            {
                "arm_group_label": "14 day quadruple therapy", 
                "intervention_name": "long duration (14 day)", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Amoxicillin", 
                "Anti-Bacterial Agents", 
                "Clarithromycin", 
                "Antibiotics, Antitubercular", 
                "Bismuth", 
                "Potassium Citrate", 
                "Proton Pump Inhibitors"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 1, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Shanghai", 
                    "country": "China", 
                    "state": "Shanghai", 
                    "zip": "200127"
                }, 
                "name": "Renji Hospital"
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "3", 
        "overall_official": {
            "affiliation": "Shanghai Jiao Tong University School of Medicine", 
            "last_name": "Hong Lu, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "To calculate and compare the efficacy of 10 day and 14 day triple therapies with and without bismuth,to examine whether long duration and addition of bismuth affects the eradication.", 
            "measure": "Eradication rate of Helicobacter pylori", 
            "safety_issue": "Yes", 
            "time_frame": "2 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01667575"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Shanghai Jiao Tong University School of Medicine", 
            "investigator_full_name": "Dr. HONG LU", 
            "investigator_title": "Professor of GI Division", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Shanghai Jiao Tong University School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shanghai Jiao Tong University School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}